Dr Reddy's Lab launches prostate cancer drug in India

Drug firm Dr Reddy's Laboratories said it has launched a cancer drug 'Pamorelin LA' in the country under an agreement with Switzerland-based Debiopharm Group. The Hyderabad-based firm has launched Pamorelin LA in India on December 3, 2012, under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland, Dr Reddy's Laboratories said in a statement.

Pamorelin LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer, it added. "Pamorelin LA will be imported in bulk from Debio Recherche Pharmaceutique. It will be made available primarily to urologists and oncologists across India," Dr Reddy's said. The company's scrip closed at Rs 1,837.10 on the BSE, down 0.56 per cent from its previous close.

Anda sedang membaca artikel tentang

Dr Reddy's Lab launches prostate cancer drug in India

Dengan url

https://kebugaranhidup.blogspot.com/2012/12/dr-reddys-lab-launches-prostate-cancer.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Dr Reddy's Lab launches prostate cancer drug in India

namun jangan lupa untuk meletakkan link

Dr Reddy's Lab launches prostate cancer drug in India

sebagai sumbernya